[ET Net News Agency, 29 February 2024] CUTIA-B (02487) rose 19.4% to HK$9.79.
It hits an intra-day high of HK$9.9, and an intra-day low of HK$8.4. The total shares
traded was 1.81 million, with a value of HK$16.35m. The active buy/sell ratio is 52:48,
with net buying turnover of HK$740,278. HSBC SEC BRO (ASIA) accounts for greatest net
responsive buying turnover of HK$989,949, with volume weighted average price of HK$8.977.
UBS accounts for greatest net responsive selling turnover of HK$1.49m, with volume
weighted average price of HK$9.066. The stock has risen a combined 65.9% over the past 8
consecutive trading days.
Basic Information
=================
---------------------------------
Nominal 9.790 % Chg +19.39%
High 9.900 Low 8.400
Shares Tr 1.81m Turnover 16.35m
10-D SMA 7.085 %H.V 150.847
20-D SMA 6.896 VWAP 9.038
50-D SMA 7.817 RSI14 69.511
---------------------------------
Status: Active buy/sell ratio is 52:48, with net buying turnover of HK$740,278, rising a
combined 65.9% over the past 8 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
CUTIA-B (02487) 9.79 +19.39
HUTCHMED (00013) 24.45 +3.16
GENSCRIPT BIO (01548) 16.02 +0.38
INNOVENT BIO (01801) 42.15 +0.24
EVEREST MED-B (01952) 24.60 +13.89
LAEKNA-B (02105) 5.82 +44.42
WUXI BIO (02269) 19.08 +3.36
BEIGENE (06160) 106.10 +1.73
ZAI LAB (09688) 17.24 -0.69
AKESO (09926) 47.55 +1.17
---------------------------------------------
(ed)